Fondaparinux vs heparin
Major bleeding · patients with cancer with venous thromboembolism
Fondaparinux showed no clear difference in major bleeding compared with heparin (low certainty).
1 finding from 1 review
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer 2021 · Cochrane Headline outcomes onlyRR 0.82 [0.4, 1.66]1 study · 477 participantsLow